Featured Research

from universities, journals, and other organizations

Amino Acid Supplements Improve Dialysis Patients' Health

Date:
June 26, 2000
Source:
Johns Hopkins Medical Institutions
Summary:
Amino acid supplements may provide a cost-effective and safe method for improving the nutritional intake of some dialysis patients who are unable to meet their daily protein requirements, a Johns Hopkins study shows.

Amino acid supplements may provide a cost-effective and safe method for improving the nutritional intake of some dialysis patients who are unable to meet their daily protein requirements, a Johns Hopkins study shows.

"The technique increases serum proteins toward normal levels," says Mackenzie Walser, M.D., senior author of the study and professor of medicine, pharmacology and molecular science at Hopkins.

Dialysis patients have low levels of protein in their blood compared to healthy individuals. Patients can't always increase the level of protein in their diet because of complications of kidney failure: a persistent poor appetite, the need for numerous medications, ongoing inflammation and related medical problems. Yet supplements of amino acids – fundamental components of all proteins – bypass these problems and are a good way to increase proteins in the blood, the authors say.

Hypoalbuminemia, or lack of sufficient protein in the blood, affects up to 40 percent of dialysis patients and is the strongest predictor of death in dialysis patients, they say. Nutritional interventions are desperately needed, Walser adds, because nearly 23 percent of dialysis patients die each year, often in association with low albumin levels.

Previous studies of dialysis patients have looked at intravenous methods of delivering amino acids, which are much more expensive. The current study, published in the June issue of the journal Kidney International, is the first randomized, double-blind controlled trial of oral supplements in this population.

"The amino acid pills were well tolerated," says Joseph A. Eustace, M.D., lead author of the study and an instructor of medicine at Hopkins. "Our work shows that simple nutritional interventions have the potential to do dialysis patients a lot of good."

Researchers studied the effects of amino acid supplements in 47 patients, 29 of whom were on hemodialysis and 18 on peritoneal dialysis. In the first method, a patient's blood is directly filtered of waste materials. In the latter, fluid is injected through a soft tube in the abdominal wall to remove toxins, and is replaced several times a day.

During the study, patients were randomly assigned to take either five amino acid pills (3.6 g) or five placebo pills with meals three times a day for three months. Albumin levels were measured at the end of each month.

At the study's conclusion, hemodialysis patients who took amino acids saw their albumin levels raised by an average of 0.22 g/dL. Peritoneal dialysis patients had an average increase of only 0.01 g/dL.

"We hope that this increase in serum albumin will result in better health and increased survival for patients treated with hemodialysis," Eustace says. Another ongoing study is measuring the effects of fewer supplements on albumin levels, he says. Further study will investigate how the amino acids increase serum albumin levels.

Eustace was supported by the National Institutes of Health. Additional study support was provided by Recip AB Arsta, Sweden. Walser is entitled to a share of royalties received by the University on sales of the product described in this article. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policy.

Other authors of the study were Josef Coresh, Ph.D.; Chris Kutchey, R.D.; Purita L. Te, R.D.; Luis F. Gimenez, M.D.; and Paul J. Scheel, Jr., M.D.

Related Web Sites:

National Kidney Foundation:http://www.kidney.org

National Institute of Diabetes & Digestive & Kidney Diseases:http://www.niddk.nih.gov/


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Amino Acid Supplements Improve Dialysis Patients' Health." ScienceDaily. ScienceDaily, 26 June 2000. <www.sciencedaily.com/releases/2000/06/000625232028.htm>.
Johns Hopkins Medical Institutions. (2000, June 26). Amino Acid Supplements Improve Dialysis Patients' Health. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2000/06/000625232028.htm
Johns Hopkins Medical Institutions. "Amino Acid Supplements Improve Dialysis Patients' Health." ScienceDaily. www.sciencedaily.com/releases/2000/06/000625232028.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins